Pari Antoniw

1.5k total citations
21 papers, 1.1k citations indexed

About

Pari Antoniw is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Pari Antoniw has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Biotechnology. Recurrent topics in Pari Antoniw's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Pari Antoniw is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Pari Antoniw collaborates with scholars based in United Kingdom and United States. Pari Antoniw's co-authors include F Searle, Shauna West, Andrew P. Chapman, Mariangela Spitali, David King, K D Bagshawe, Springer Cj, Caroline J. Springer, RG Melton and R.F. Sherwood and has published in prestigious journals such as Nature Biotechnology, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Pari Antoniw

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pari Antoniw United Kingdom 15 684 659 281 174 149 21 1.1k
F Searle United Kingdom 19 685 1.0× 767 1.2× 334 1.2× 164 0.9× 186 1.2× 52 1.4k
Kenneth D. Bagshawe United Kingdom 21 570 0.8× 461 0.7× 266 0.9× 121 0.7× 181 1.2× 44 1.3k
D C Blakey United Kingdom 17 582 0.9× 385 0.6× 272 1.0× 276 1.6× 104 0.7× 38 1.1k
G.T. Rogers United Kingdom 18 506 0.7× 549 0.8× 228 0.8× 84 0.5× 121 0.8× 53 960
Dan Shochat United States 17 464 0.7× 498 0.8× 399 1.4× 42 0.2× 128 0.9× 28 1.1k
Ingmarie Höidén‐Guthenberg Sweden 17 808 1.2× 987 1.5× 381 1.4× 95 0.5× 64 0.4× 17 1.3k
Gary R. Braslawsky United States 20 570 0.8× 496 0.8× 372 1.3× 69 0.4× 142 1.0× 34 1.2k
Sandra J. Hofstead United States 14 728 1.1× 659 1.0× 636 2.3× 104 0.6× 417 2.8× 14 1.6k
Robert S. Greenfield United States 17 480 0.7× 388 0.6× 334 1.2× 49 0.3× 169 1.1× 43 1.3k
Shirley J. Lasch United States 11 600 0.9× 722 1.1× 680 2.4× 69 0.4× 151 1.0× 11 1.4k

Countries citing papers authored by Pari Antoniw

Since Specialization
Citations

This map shows the geographic impact of Pari Antoniw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pari Antoniw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pari Antoniw more than expected).

Fields of papers citing papers by Pari Antoniw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pari Antoniw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pari Antoniw. The network helps show where Pari Antoniw may publish in the future.

Co-authorship network of co-authors of Pari Antoniw

This figure shows the co-authorship network connecting the top 25 collaborators of Pari Antoniw. A scholar is included among the top collaborators of Pari Antoniw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pari Antoniw. Pari Antoniw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Humphreys, David P., Sam Heywood, Alistair J. Henry, et al.. (2007). Alternative antibody Fab′ fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering. Protein Engineering Design and Selection. 20(5). 227–234. 37 indexed citations
2.
Weir, A. Neil C., Andrew Nesbitt, Andrew P. Chapman, et al.. (2002). Formatting antibody fragments to mediate specific therapeutic functions. Biochemical Society Transactions. 30(3). A68–A68. 2 indexed citations
3.
Smith, Bryan John, Andrew G. Popplewell, Andrew P. Chapman, et al.. (2001). Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin. Bioconjugate Chemistry. 12(5). 750–756. 61 indexed citations
4.
Chapman, Andrew P., et al.. (1999). Therapeutic antibody fragments with prolonged in vivo half-lives. Nature Biotechnology. 17(8). 780–783. 258 indexed citations
5.
Humphreys, David P., Andrew P. Chapman, David J. King, et al.. (1998). F(ab′)2 molecules made from Escherichia coli produced Fab′ with hinge sequences conferring increased serum survival in an animal model. Journal of Immunological Methods. 217(1-2). 1–10. 24 indexed citations
6.
Antoniw, Pari, Alison Turner, Angela Mountain, et al.. (1996). Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM). British Journal of Cancer. 74(4). 513–524. 26 indexed citations
7.
Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations
8.
King, DJ, Pari Antoniw, Raymond J. Owens, et al.. (1995). Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy. British Journal of Cancer. 72(6). 1364–1372. 68 indexed citations
9.
Norman, Timothy J., David Parker, Louise Royle, et al.. (1995). Improved tumour targeting with recombinant antibody–macrocycle conjugates. Journal of the Chemical Society Chemical Communications. 1877–1878. 17 indexed citations
10.
Cj, Springer, et al.. (1992). Antibody directed enzyme prodrug therapy (ADEPT): a three phase system.. PubMed. 9(3-4). 225–31. 47 indexed citations
11.
Bagshawe, K. D., Shruti Sharma, Caroline J. Springer, et al.. (1992). Antibody directed enzyme prodrug therapy (ADEPT): clinical report.. PubMed. 9(3-4). 233–8. 58 indexed citations
12.
Bagshawe, K D, et al.. (1991). ANTIBODY-ENZYME CONJUGATES CAN GENERATE CYTOTOXIC DRUGS FROM INACTIVE PRECURSORS AT TUMOR SITES. UCL Discovery (University College London). 4 indexed citations
13.
Springer, Caroline J., Kenneth D. Bagshawe, Surinder K. Sharma, et al.. (1991). Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. European Journal of Cancer and Clinical Oncology. 27(11). 1361–1366. 86 indexed citations
14.
Springer, Caroline J., Pari Antoniw, K D Bagshawe, & D. E. V. Wilman. (1991). Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT).. PubMed. 6(5). 467–79. 20 indexed citations
15.
Antoniw, Pari, Springer Cj, K D Bagshawe, et al.. (1990). Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice. British Journal of Cancer. 62(6). 909–914. 38 indexed citations
16.
Springer, Caroline J., et al.. (1990). Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. Journal of Medicinal Chemistry. 33(2). 677–681. 100 indexed citations
17.
Bagshawe, K D, Springer Cj, F Searle, et al.. (1988). A cytotoxic agent can be generated selectively at cancer sites. British Journal of Cancer. 58(6). 700–703. 205 indexed citations
18.
Pedley, R. Barbara, et al.. (1987). Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines. Cancer Chemotherapy and Pharmacology. 19(3). 221–5. 7 indexed citations
19.
Antoniw, Pari, et al.. (1986). Plasma and tissue disposition of mitozolomide in mice. British Journal of Cancer. 53(1). 91–97. 8 indexed citations
20.
Antoniw, Pari, et al.. (1985). Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma. Cancer Chemotherapy and Pharmacology. 15(1). 66–71. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Searle Breakdown of academic impact, for papers by Kenneth D. Bagshawe Breakdown of academic impact, for papers by D C Blakey Breakdown of academic impact, for papers by G.T. Rogers Breakdown of academic impact, for papers by Dan Shochat Breakdown of academic impact, for papers by Ingmarie Höidén‐Guthenberg Breakdown of academic impact, for papers by Gary R. Braslawsky Breakdown of academic impact, for papers by Sandra J. Hofstead Breakdown of academic impact, for papers by Robert S. Greenfield Breakdown of academic impact, for papers by Shirley J. Lasch
Rankless by CCL
2026